DK193588A - Anvendelser af dopaminagonister - Google Patents
Anvendelser af dopaminagonisterInfo
- Publication number
- DK193588A DK193588A DK193588A DK193588A DK193588A DK 193588 A DK193588 A DK 193588A DK 193588 A DK193588 A DK 193588A DK 193588 A DK193588 A DK 193588A DK 193588 A DK193588 A DK 193588A
- Authority
- DK
- Denmark
- Prior art keywords
- dopaminagonists
- applications
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878708626A GB8708626D0 (en) | 1987-04-10 | 1987-04-10 | Indolophenanthridines |
| GB878708898A GB8708898D0 (en) | 1987-04-14 | 1987-04-14 | Indolophenanthridines |
| GB878710062A GB8710062D0 (en) | 1987-04-28 | 1987-04-28 | Indolophenanthridines |
| GB878720366A GB8720366D0 (en) | 1987-08-28 | 1987-08-28 | Dopamine d1 receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK193588D0 DK193588D0 (da) | 1988-04-08 |
| DK193588A true DK193588A (da) | 1988-10-11 |
Family
ID=27449909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK193588A DK193588A (da) | 1987-04-10 | 1988-04-08 | Anvendelser af dopaminagonister |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4855306A (da) |
| JP (1) | JPS63258819A (da) |
| KR (1) | KR880012227A (da) |
| AU (1) | AU1440088A (da) |
| DE (1) | DE3811274A1 (da) |
| DK (1) | DK193588A (da) |
| FR (1) | FR2613623A1 (da) |
| GB (1) | GB2205495A (da) |
| IT (1) | IT1219906B (da) |
| NL (1) | NL8800823A (da) |
| SE (1) | SE8801275A0 (da) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1006794B1 (en) * | 1997-03-12 | 2007-11-28 | Robert W. Esmond | A method for treating or preventing alzheimer's disease |
| US20040058873A1 (en) * | 1998-03-12 | 2004-03-25 | Esmond Robert W. | Method for treating or preventing Alzheimer's disease |
| US6541669B1 (en) * | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
| DE10148233A1 (de) * | 2001-09-28 | 2003-04-10 | Boehringer Ingelheim Pharma | Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme |
| US20050215552A1 (en) * | 2002-05-17 | 2005-09-29 | Gadde Kishore M | Method for treating obesity |
| MXPA04011203A (es) * | 2002-05-17 | 2005-07-14 | Univ Duke | Metodo para tratar la obesidad. |
| DE10312809A1 (de) * | 2003-03-21 | 2004-09-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern |
| US20040266794A1 (en) * | 2003-03-21 | 2004-12-30 | Boehringer Ingelheim International Gmbh | Pramipexole for the reduction of excessive food intake for children |
| WO2004096201A1 (en) | 2003-04-29 | 2004-11-11 | Orexigen Therapeutics, Inc. | Compositions for affecting weight loss |
| EP1626703A2 (en) * | 2003-05-22 | 2006-02-22 | Yeda Research And Development Co. Ltd. | Dopamine and agonists and antagonists thereof for modulation of suppressive activity of cd4+cd25+ regulatory t cells |
| EP1734955A2 (en) * | 2004-01-13 | 2006-12-27 | Duke University | Compositions of an anticonvulsant and an antipsychotic drug for affecting weigt loss |
| US7713959B2 (en) * | 2004-01-13 | 2010-05-11 | Duke University | Compositions of an anticonvulsant and mirtazapine to prevent weight gain |
| EP1748776A1 (en) * | 2004-05-03 | 2007-02-07 | Duke University | Compositions for affecting weight loss |
| WO2006119353A2 (en) * | 2005-05-03 | 2006-11-09 | University Of South Carolina | Dopamine receptor agonists in the treatment and prevention of hiv-induced dementia |
| ES2761812T3 (es) | 2005-11-22 | 2020-05-21 | Nalpropion Pharmaceuticals Inc | Composición y métodos de aumento de la sensibilidad a la insulina |
| US8916195B2 (en) | 2006-06-05 | 2014-12-23 | Orexigen Therapeutics, Inc. | Sustained release formulation of naltrexone |
| DK2089005T3 (da) | 2006-11-09 | 2010-07-19 | Orexigen Therapeutics Inc | Lagdelte farmaceutiske formuleringer omfattende et hurtigt opløsende mellemlag |
| KR20150082689A (ko) | 2006-11-09 | 2015-07-15 | 오렉시젠 세러퓨틱스 인크. | 단위 용량 팩키지 |
| WO2009158114A1 (en) | 2008-05-30 | 2009-12-30 | Orexigen Therapeutics, Inc. | Methods for treating visceral fat conditions |
| AU2010287336B2 (en) * | 2009-08-27 | 2013-07-25 | Daikin Industries, Ltd. | Processing additive, molding composition, masterbatch of processing additive and molding article |
| CN102724878A (zh) | 2010-01-11 | 2012-10-10 | 奥雷西根治疗公司 | 在重度抑郁症患者中提供体重减轻疗法的方法 |
| HUE072188T2 (hu) | 2012-06-06 | 2025-10-28 | Nalpropion Pharmaceuticals Llc | Készítmény magas kardiovaszkuláris kockázatú túlsúlyos és elhízott páciensek kezelésére szolgáló eljárásban történõ alkalmazásra |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3402392A1 (de) * | 1984-01-25 | 1985-08-01 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue ergolinderivate, deren herstellung und deren verwendung |
-
1988
- 1988-03-31 NL NL8800823A patent/NL8800823A/nl not_active Application Discontinuation
- 1988-04-01 FR FR8804499A patent/FR2613623A1/fr not_active Withdrawn
- 1988-04-02 DE DE3811274A patent/DE3811274A1/de not_active Withdrawn
- 1988-04-05 IT IT47814/88A patent/IT1219906B/it active
- 1988-04-07 GB GB08808125A patent/GB2205495A/en active Pending
- 1988-04-07 US US07/178,668 patent/US4855306A/en not_active Expired - Fee Related
- 1988-04-08 DK DK193588A patent/DK193588A/da not_active Application Discontinuation
- 1988-04-08 AU AU14400/88A patent/AU1440088A/en not_active Abandoned
- 1988-04-08 SE SE8801275A patent/SE8801275A0/sv not_active Application Discontinuation
- 1988-04-09 KR KR1019880004023A patent/KR880012227A/ko not_active Withdrawn
- 1988-04-09 JP JP63088033A patent/JPS63258819A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NL8800823A (nl) | 1988-11-01 |
| GB2205495A (en) | 1988-12-14 |
| IT1219906B (it) | 1990-05-24 |
| DK193588D0 (da) | 1988-04-08 |
| JPS63258819A (ja) | 1988-10-26 |
| IT8847814A0 (it) | 1988-04-05 |
| DE3811274A1 (de) | 1988-10-27 |
| SE8801275L (sv) | 1988-10-19 |
| GB8808125D0 (en) | 1988-05-11 |
| FR2613623A1 (fr) | 1988-10-14 |
| SE8801275A0 (sv) | 1988-10-19 |
| KR880012227A (ko) | 1988-11-26 |
| US4855306A (en) | 1989-08-08 |
| AU1440088A (en) | 1988-10-13 |
| SE8801275D0 (sv) | 1988-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK193588D0 (da) | Anvendelser af dopaminagonister | |
| DK208188D0 (da) | Anvendelse af 17-ketosteroider | |
| DK450189D0 (da) | Strimmel af sammenfoejede soem | |
| DK363887A (da) | Anvendelse af bromcruptin | |
| DK348385D0 (da) | Anvendelse af cyclosporiner | |
| DK662687A (da) | Anvendelse af tricycliske carbazoloner | |
| DK549688D0 (da) | Fremstilling af peptider | |
| DK25389D0 (da) | Tolkning af elektriske diagrafier | |
| DK185988A (da) | Anvendelse af antigen | |
| DK360484D0 (da) | Modifikation af soja-isolat | |
| DK38593A (da) | Alkoxymethylethere af glyceroler | |
| DK102389A (da) | Anvendelse af interleukin | |
| DK119688A (da) | 23-oxo- (-keto-) og 23-imino-derivater af mono- og diepoxy-ll-f28249-forbindelser | |
| DK316589D0 (da) | Substituerede azacyclohexylderivater af rifamyciner | |
| DK104489D0 (da) | Anvendelse af triazolderivater | |
| DK562289D0 (da) | Anvendelse af somatostatiner | |
| DK541487D0 (da) | Sammenfoejning af materialer | |
| DK293787D0 (da) | Ekspression af en amyloglucosidase | |
| DK251788D0 (da) | Stabile creatinamidinohydrolasemutanter | |
| DK426089D0 (da) | Omestring af phospholipider | |
| DK105089D0 (da) | Fremstilling af bis(amin-holdige)benzendioler | |
| DK487289D0 (da) | Omestring af phospholipider | |
| DK185987D0 (da) | Anvendelse af prostaglandiner | |
| DK153045C (da) | Sammenkobling af fortrinsvis langstrakte elementer | |
| DK621088D0 (da) | Theemballage af theposetypen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |